Delhi Journal of Ophthalmology

Response of Autologous Serum Supratarsal Injection in Patients of Vernal Keratoconjunctivitis in Longterm Followup

Ritu Agarwal, Jai Shree Murli Manoher
Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India

Editor-in-Chief, Delhi Journal of Ophthalmology, Dr R.P.Centre, AIIMS.


Corresponding Author:

Ritu Agarwal
Department of Ophthalmology 
Jawaharlal Nehru Medical College,
Ajmer, Rajasthan, India
Email id: agarwal.dr.ritu.09@gmail.com


Received: 22-JAN-2019 Accepted: 19-SEP-2019 Published Online: 27-FEB-2020
DOI: https://dx.doi.org/10.7869/djo.500

Abstract
Purpose: To study the response of 0.1 ml autologous serum supratarsal injection in patients of vernal keratoconjunctivitis in their long term followup. 
Materials and Methods: This prospective, nonrandomized study was carried out in 50 patients of either sex and any age suffering from vernal keratoconjunctivitis. Previous medications were discontinued for period of 15 days before commencing serum injection. 0.1 ml of autologous serum was injected in each eye supratarsaly. Injection was repeated every week for 8 weeks and follow up of all patients was done at one month, three months, six months and one-year interval. 
Results: Significant improvements in symptoms and some of the signs were achieved. Improvement was significant even after discontinuation of treatment. No additional medications were required. 
Conclusions: 0.1 ml supratarsal injection of autologous serum is an effective alternative treatment in vernal for long term and without any adverse effects.

Keywords :Vernal Keratoconjunctivitis, autologous serum, long term